Compare JOINN Laboratories (China) Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 31,893 Million ()
NA (Loss Making)
NA
0.05%
-0.29
-1.26%
3.28
Revenue and Profits:
Net Sales:
357 Million
(Quarterly Results - Mar 2026)
Net Profit:
269 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.1%
0%
8.1%
6 Months
-7.48%
0%
-7.48%
1 Year
9.49%
0%
9.49%
2 Years
213.87%
0%
213.87%
3 Years
11.55%
0%
11.55%
4 Years
-70.09%
0%
-70.09%
5 Years
-81.29%
0%
-81.29%
JOINN Laboratories (China) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.53%
EBIT Growth (5y)
-195.37%
EBIT to Interest (avg)
57.67
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.27
Tax Ratio
8.97%
Dividend Payout Ratio
31.78%
Pledged Shares
0
Institutional Holding
0.78%
ROCE (avg)
8.73%
ROE (avg)
6.56%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.23
EV to EBIT
2.34
EV to EBITDA
5.05
EV to Capital Employed
-0.09
EV to Sales
-0.32
PEG Ratio
NA
Dividend Yield
0.70%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.78%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
356.70
307.20
16.11%
Operating Profit (PBDIT) excl Other Income
-53.40
-3.30
-1,518.18%
Interest
0.30
0.60
-50.00%
Exceptional Items
319.40
70.40
353.69%
Consolidate Net Profit
269.00
44.00
511.36%
Operating Profit Margin (Excl OI)
-149.70%
-146.60%
-0.31%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 16.11% vs -13.07% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 511.36% vs 114.79% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,797.30
2,186.60
-17.80%
Operating Profit (PBDIT) excl Other Income
36.70
236.50
-84.48%
Interest
1.80
3.00
-40.00%
Exceptional Items
393.80
-137.70
385.98%
Consolidate Net Profit
323.00
75.60
327.25%
Operating Profit Margin (Excl OI)
-78.30%
34.70%
-11.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -17.80% vs -16.98% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 327.25% vs -82.53% in Dec 2024
About JOINN Laboratories (China) Co., Ltd. 
JOINN Laboratories (China) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






